News and Announcements
Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
09.30.2025Biological markers may help predict which patients will benefit most from specific therapies to treat prostate cancer, according to a study published in the journal Cell.
08.20.2025In Episode 155 of Sex Advice for Seniors, titled “The Intersection of Prostate Cancer and Sexual Function,” host Suzanne Noble sits down with Peter N. Tsambarlis, MD, for a candid, insightful conversation. They delve into the nuanced effects of prostate cancer and its treatments on erectile health, exploring prevention strategies, the impact of surgery, the role of medications and lifestyle choices, and the critical importance of assembling a supportive healthcare team. The discussion also touches on navigating sensitive topics like Peyronie’s disease, how to broach difficult but essential health conversations without shame, and why cardiovascular wellness matters to sexual function.
07.31.2025Northwestern Medicine investigators have discovered a new combination approach that may improve the efficacy of MYC inhibitor drugs for treating aggressive and treatment-resistant cancers, according to a recent Northwestern Medicine study published in Science Advances.
06.04.2025Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by exploiting their hidden metabolic vulnerabilities, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
05.23.2025Northwestern Medicine investigators have discovered that a novel long noncoding RNA, which are usually 200 nucleotides longer than typical RNAs, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances.
02.06.2025Amy E. Krambeck, MD, discusses the key advantages of holmium laser enucleation of the prostate (HoLEP), highlighting its effectiveness, precision, and benefits for patient recovery.
01.30.2025In this video, Urology Times features Amy E. Krambeck, MD, as she reflects on Northwestern’s achievement of performing 754 holmium laser enucleation of the prostate (HoLEP) procedures in 2024. “This milestone is a testament to our efficiency and the exceptional quality of care patients receive at Northwestern,” says Dr. Krambeck
01.14.2025A team of Northwestern scientists have developed a novel “scaffolding” biomaterial that improves bladder tissue regeneration and overall function better than current techniques.
12.20.2024The use of active surveillance and watchful waiting increased from 13.2 percent in 2010 to 53.8 percent in 2020 among patients with intermediate-risk prostate cancer, according to a recent study published in JAMA.
12.16.2024A new blood test may help reduce unnecessary prostate biopsies and can detect prostate cancer with similar sensitivity to standard screening in patients across racial and ethnic groups, according to a recent study published in the Journal of Clinical Oncology.
12.09.2024Northwestern Medicine investigators have discovered new molecular mechanisms underlying DNA repair dysregulation in cancer cells, findings that may inform the development of new targeted therapies for patients that have become resistant to standard treatments.
11.21.2024As part of the “Voices” series presented by the Diversity, Equity & Inclusion Committee, this episode features an inspiring conversation between Dr. Gjanje Smith-Mathus, a female pelvic medicine and reconstructive surgeon at WakeMed and founder of the Susu Health Foundation, and Dr. Jennifer Miles-Thomas, Vice Chair of Integration and Innovation at the Northwestern Medicine Department of Urology and AUA treasurer-elect. Dr. Miles-Thomas shares her historic journey as the first woman—and woman of color—on the AUA Board of Directors, highlighting the significance of representation and diversity in leadership within the medical field.
11.12.2024Eric Li, MD, a PGY-6 urology resident, provides an overview of the background and notable findings from the Journal of Urology article, “Clinical Factors Associated with Suspicious 18F-DCFPyL PSMA PET Activity in Patients Initially Managed with Radical Prostatectomy, Including PSA <0.5 ng/mL.”
11.01.2024In this episode of Better Edge, Hiten D. Patel, MD, explores his groundbreaking research on harnessing artificial intelligence to enhance the accuracy of prostate cancer detection and staging. Dr. Patel shares insights into the transformative potential of AI in revolutionizing diagnostic precision and improving patient outcomes in prostate cancer care.